Condition

Lymphoproliferative Disorders clinical trials and research

• 14Clinical trials
• 1NIH research projects
• 9Countries

Newest Lymphoproliferative Disorders clinical trials

All recruiting trials (14)

• Chemogenomic profiling for blood cancers

  This project will test whether detailed genetic and molecular profiling of bone marrow, blood, or tissue samples can better characterize diagnosis and relapse for people with suspected or known blood cancers.

  Recruiting Azienda Ospedaliero-Universitaria di Parma · Parma, PR · NCT07445984

• Multi-omics testing for blood and bone marrow cancers

  This project will test a multi-omics lab approach on bone marrow, blood, biopsy and other fluid samples from people with suspected or known hematologic cancers to see if it can better characterize their disease.

  Recruiting Azienda Ospedaliero-Universitaria di Parma · Parma, PR · NCT07445438

• Dabrafenib and trametinib for rare cancers with BRAF V600 mutations

  This arm tests whether dabrafenib and trametinib can help adults, children, and teens with cancers that have a BRAF V600 mutation.

  Recruiting at 15 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT07440290

• KLN-1010 gene therapy for relapsed or refractory multiple myeloma

  This Phase 1 trial will try KLN-1010, an in vivo CAR‑T gene therapy, to see if it is safe and can be given at a tolerable dose for people with relapsed or refractory multiple myeloma who have had at least three prior therapies.

  Recruiting at 11 sites Phase 1 Kelonia Therapeutics, Inc. · Duarte, California and 10 other locations · NCT07075185

• Evaluating a new CAR-T cell therapy for relapsed/refractory multiple myeloma

  This study is testing a new CAR-T cell therapy called OriCAR-017 to see if it can help people with relapsed or refractory multiple myeloma feel better and improve their treatment outcomes.

  Recruiting Phase 1 OriCell Therapeutics Co., Ltd. · Atlanta, Georgia · NCT06271252

• Virtual rehabilitation program for cancer survivors

  This study is testing an 8-week online rehab program for cancer survivors to see if it helps them feel better physically and socially after treatment.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT05898789

• Entrectinib treatment for patients with ROS1-positive cancers

  This study is testing if the drug entrectinib can help people with different types of cancers that have a ROS1 gene fusion, including adults and kids, to see if it works better than what’s currently available.

  Recruiting at 24 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT05770544

• Using atezolizumab to treat cancers with high mutation rates or specific genetic deficiencies

  This study is testing if atezolizumab can help treat adults and kids with certain types of cancers that have a lot of genetic changes or specific genetic issues.

  Recruiting at 23 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT05770102

• Alectinib treatment for ALK-positive cancers in adults and children

  This study is testing if alectinib, a drug for lung cancer, can help treat different types of ALK-positive cancers in both adults and children.

  Recruiting at 24 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT05770037

• Using pacritinib to treat relapsed or refractory T-cell lymphoproliferative neoplasms

  This study is testing if the oral medication pacritinib can help people with certain types of T-cell lymphomas that have come back or didn’t respond to other treatments.

  Recruiting at 4 sites Phase 2 University of Michigan Rogel Cancer Center · Duarte, California and 5 other locations · NCT04858256

• Stem cell transplant for patients with immune system disorders

  This study is testing if a stem cell transplant from a matched donor can help people aged 4 to 69 with immune system disorders feel better and improve their health.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT04339777

• Treatment for Epstein-Barr Virus-Associated Lymphoproliferative Disease After Transplant

  This study is testing a new treatment called tabelecleucel for patients with a specific type of cancer related to Epstein-Barr virus who haven't improved with other therapies after receiving a transplant.

  Recruiting at 35 sites Phase 3 Pierre Fabre Medicament · Duarte, California and 70 other locations · NCT03394365

• Transplantation of blood or marrow for treating immune system disorders

  This study is testing if getting blood or marrow transplants from healthy donors can help people aged 4 to 75 with serious immune system disorders feel better and stay healthy.

  Recruiting at 2 sites Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland and 1 other locations · NCT02579967

• Creating a tumor bank for families with multiple blood cancers

  This study is trying to collect samples from families with multiple blood cancers to see if there are specific genetic factors that make them more likely to develop lymphomas.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT00131014

NIH-funded research (1)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Predicting PTLD risk and treatment response in transplant patients using EBV and host immune factors

  Aimed at people who have had organ transplants, this project looks for viral and immune clues to predict who might develop PTLD and how well treatment might work.

  NIH research Ohio State University · Columbus, UNITED STATES · NIH-11279989

Related topics

Quick answers

How many Lymphoproliferative Disorders clinical trials are recruiting right now?

14, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 9 countries. The most sites are in United States (7 trials), United Kingdom (5 trials), Italy (3 trials), Australia (2 trials), Canada (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2/3: 4, Phase 2: 3, Phase 1: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →